AI Agents Battleground, Xiaomi's Living Room EV and IPO Winners and Losers

What happened in China this week: China’s Big Policy Week: Carbon, Helium, E-Commerce, Medicine and Wages AI Agents Are a Battleground in China, Xiaowei Is Our Pick 102 HK IPOs in 2026: 59 Winners, 41 Losers, and One Stock Up 1,311% Xiaomi’s Third EV Is a Reconfigurable SUV That Doubles as a Living Room Han’s CNC Records 104% Revenue Growth Thanks To AI Boom Beijing has been busy. Over the past stretch, China rolled out a cluster of policies spanning energy, trade, e-commerce, healthcare and wages. None of them are small. Here’s what changed and why it matters. China’s 2026 to 2030 Dual Carbon Action Plan sets a target to cut carbon emissions per unit of GDP by 17% from 2025 levels within five years. The policy pushes non fossil energy to 25% of total energy consumption through large investments in wind, solar, nuclear, energy storage and long distance power transmission lines built to carry electricity with minimal loss. It also promotes zero carbon industrial parks, zero carbon factories and greener data centres, alongside faster adoption of electric vehicles. Taken together, the plan confirms that energy security and industrial decarbonisation remain a long term priority for Beijing, not a passing initiative. China has also placed a temporary ban on helium exports to strengthen supply chain resilience. The goal is to keep domestic supply flowing to strategic industries such as semiconductors, aerospace and healthcare, after global helium shortages caused by geopolitical disruption. Helium is a critical input in advanced chip manufacturing, so this move fits Beijing’s broader push for technological self sufficiency and its strategy to localise semiconductor production. China released draft revisions to its E-Commerce Law to modernise how the digital economy is regulated. The proposed reforms introduce stricter oversight of platform operators, impose fines of up to 5% of revenue for serious anti competitive conduct, formally bring gig workers under legal protection, and create a coordinated mechanism across government agencies. The draft also expands Beijing’s authority to respond to discriminatory foreign trade measures with reciprocal action, another sign that China wants tighter digital governance while shielding domestic firms. China updated its National Essential Medicines List for the first time in eight years , expanding it from 678 to 794 medicines. The 116 additions include innovative treatments such as semaglutide, bevacizumab, olaparib and RemeGen’s lupus drug telitacicept. Public hospitals are now required to stock these medicines, which widens patient access and opens up sales opportunities for pharmaceutical companies. The update also expands treatment options for chronic diseases including diabetes, hypertension and chronic obstructive pulmonary disease, adds 31 paediatric medicines to address a shortage of child specific formulations, and gives more weight to traditional Chinese medicine. By aligning the essential medicines list with the national medical insurance catalogue, Beijing ensures these drugs are both available and affordable, while signalling that future updates will come more frequently. Finally, China introduced a new wage reform blueprint under its 15th Five Year Plan to support employment, raise household incomes and stimulate consumption. The policy promotes collective bargaining over wages, improves how minimum wages are adjusted, expands vocational training in AI, advanced manufacturing and other strategic industries, and aims to grow the middle income population while protecting frontline workers. The reforms are also designed to keep inflation on a steady, moderate path, a notable goal given how weak China’s inflation has been recently. Taken as a whole, this is Beijing playing offence and defence at once. Locking down critical resources and tightening digital governance on one hand, while opening up healthcare access and trying to lift household incomes on the other. Investors watching China exposure, whether through semiconductors, healthcare or consumption plays, have several threads to track from this single stretch of policy.